SCHEMBL3569355

SCHEMBL3569355

COc1ccc(N/C=C2\C(=O)NCc3ccc(Br)cc32)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.43
PIM1 P11309 2/20 0.42
PIM3 Q86V86 2/20 0.42
PIM2 Q9P1W9 2/20 0.42
ALDH1A1 P00352 6/20 0.41
MAPT P10636 6/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
PKM P14618 1/20 0.41
GAA P10253 4/20 0.41
HPGD P15428 1/20 0.41
KDR P35968 1/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 3/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
APP P05067 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3569356 1.00 HSP90AA1 (0.43) HSP90AA1PIM1PIM3PIM2ALDH1A1
SCHEMBL3563362 0.91 PIM1 (0.44) HSP90AA1PIM1PIM3PIM2ALDH1A1
SCHEMBL3563364 0.91 PIM1 (0.44) HSP90AA1PIM1PIM3PIM2ALDH1A1
SCHEMBL3570020 0.81 MAPKAPK2 (0.40) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL3570018 0.81 MAPKAPK2 (0.40) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL3568103 0.78 TNIK (0.46) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL3568104 0.78 TNIK (0.46) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL3575313 0.77 PIM1 (0.50) PIM1ALDH1A1MAPTNPC1RAB9A
SCHEMBL3575311 0.77 PIM1 (0.50) PIM1ALDH1A1MAPTNPC1RAB9A
SCHEMBL3576280 0.75 CDK4 (0.42) PIM1PIM3PIM2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US claimed
US-7713994-B2 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo,1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihyro-3 (2H)-isoquinolones and methods of use thereof WYETH LLC (US) 2010-05-11 US disclosed
EP-1963273-A2 SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITORS Wyeth a Corporation of the State of Delaware (US) 2008-09-03 EP disclosed
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof WYETH (US) 2008-04-10 US disclosed
WO-2007075783-A2 SUBSTITUTED ISOQUINOLINE-1,3(2H,4H)-DIONES, 1-THIOXO-1,4-DIHYDRO-2H-ISOQUINOLINE-3-ONES AND 1,4-DIHYDRO-3(2H)-ISOQUINOLONES AND USE THEREOF AS KINASE INHIBITOR WYETH (US) 2007-07-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085890-A1 Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3 (2H)-isoquinolones and methods of use thereof SULT1E1, RECQL, HAX1 HSP90AA1 1814/4885PIM1 2882/4885PIM3 2877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.